Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 2/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4510651 | 0.75 | GAA (0.52) | CA12CA9ALDH1A1HPGDKDM4E | |
| SCHEMBL10558990 | 0.73 | RYR2 (0.48) | CA12CA9ALDH1A1HPGDKDM4E | |
| SCHEMBL8526616 | 0.72 | RYR2 (0.47) | CA12CA9ALDH1A1HPGDKDM4E | |
| SCHEMBL13939432 | 0.69 | CA12 (0.63) | CA12CA9ALDH1A1HPGDKDM4E | |
| SCHEMBL9710518 | 0.68 | CA12 (0.39) | CA12CA9RYR2MEN1KMT2A | |
| SCHEMBL14061414 | 0.67 | CA12 (0.56) | CA12CA9PARP1PDPK1PARP10 | |
| SCHEMBL7146808 | 0.67 | ALOX15 (0.51) | ALDH1A1HPGDKDM4ERYR2MEN1 | |
| SCHEMBL1498003 | 0.67 | ALDH1A1 (0.59) | ALDH1A1HPGDKDM4ERYR2MEN1 | |
| SCHEMBL10463774 | 0.67 | ALDH1A1 (0.64) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL8562468 | 0.66 | NOX1 (0.58) | HPGDMEN1KMT2ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1579011-A4 | MODULATION OF DEATH-ASSOCIATED PROTEIN KINASE 1 EXPRESSION | ISIS PHARMACEUTICALS INC (US) | 2007-10-31 | — | — | EP | disclosed |
| EP-1579006-A2 | MODULATION OF JAGGED 1 EXPRESSION | Isis Pharmaceuticals, Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1579011-A2 | MODULATION OF DEATH-ASSOCIATED PROTEIN KINASE 1 EXPRESSION | Isis Pharmaceuticals, Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1532160-A2 | ANTISENSE MODULATION OF INSULIN-LIKE GROWTH FACTOR 2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004053083-A2 | MODULATION OF FETOPROTEIN TRANSCRIPTION FACTOR EXPRESSION | ISIS PHARMACEUTICALS INC. (US) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004048531-A2 | MODULATION OF DEATH-ASSOCIATED PROTEIN KINASE 1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-06-10 | — | — | WO | disclosed |
| WO-2004048601-A2 | MODULATION OF B7H EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-06-10 | — | — | WO | disclosed |
| WO-2004048325-A2 | MODULATION OF JAGGED 1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-06-10 | — | — | WO | disclosed |
| US-20040110156-A1 | Modulation of NRF expression | ISIS PHARMACEUTICALS INC. | 2004-06-10 | — | — | US | disclosed |
| WO-2004048533-A2 | MODULATION OF FORKHEAD BOX C2 EXPRESSION | ISIS, PHARMACEUTICALS (US) | 2004-06-10 | — | — | WO | disclosed |
| WO-2004048534-A2 | MODULATION OF CYTOKINE-INDUCIBLE KINASE EXPRESSION | ISIS PARMACEUTICALS, INC. (US) | 2004-06-10 | — | — | WO | disclosed |
| WO-2004046326-A2 | MODULATION OF INTERLEUKIN 22 RECEPTOR EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004046325-A2 | MODULATION OF SERINE/THREONINE KINASE 16 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004045527-A2 | MODULATION OF NIMA-RELATED KINASE 6 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004011623-A2 | ANTISENSE MODULATION OF PTPRA EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-02-05 | — | — | WO | disclosed |
| WO-2004005461-A2 | ANTISENSE MODULATION OF INSULIN-LIKE GROWTH FACTOR 2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-01-15 | — | — | WO | disclosed |
| WO-2003105754-A2 | ANTISENSE MODULATION OF VEGF-B EXPRESSION | ISIS PHARMACEUTICALS INC. (US) | 2003-12-24 | — | — | WO | disclosed |
| WO-2003106711-A1 | ANTISENSE MODULATION OF EXTRACELLULAR-SIGNAL REGULATED KINASE-6 EXPRESSION | ISIS PHARMACEUTICALS INC. (US) | 2003-12-24 | — | — | WO | disclosed |
| EP-1328536-A1 | ANTISENSE MODULATION OF GLIOMA-ASSOCIATED ONCOGENE-1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2003-07-23 | — | — | EP | disclosed |
| WO-2002020549-A1 | ANTISENSE MODULATION OF GLIOMA-ASSOCIATED ONCOGENE-1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |